Search research articles
Contact Us
Filters
Showing results (281-290 of 294) with videos related to
Page
of 30
Sort By:
Bone Marrow Transplantation
|
April 26, 2016
Allogeneic stem cell transplantation for patients with mantle cell lymphoma who failed autologous stem cell transplantation: a national survey of the SFGM-TC
B Tessoulin, P Ceballos, P Chevallier, et al.
Journal of Internal Medicine
|
December 8, 2017
Distinct factors determine the kinetics of disease relapse in adults transplanted for acute myeloid leukaemia
C Craddock, J Versluis, M Labopin, et al.
Blood Cancer Journal
|
December 10, 2016
Acute lymphoblastic leukemia relapsing after first-line pediatric-inspired therapy: a retrospective GRAALL study
A Desjonquères, P Chevallier, X Thomas, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
July 13, 2011
Double reduced-intensity allogeneic hematopoietic stem cell transplantation: a retrospective study from the SFGM-TC
J O Bay, A Cabrespine, C Faucher, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 16, 2017
Reduced-intensity versus reduced-toxicity myeloablative fludarabine/busulfan-based conditioning regimens for allografted non-Hodgkin lymphoma adult patients: a retrospective study on behalf of the Société Francophone de Greffe de Moelle et de Thérapie Cellulaire
A Le Bourgeois, M Labopin, D Blaise, et al.
Bone Marrow Transplantation
|
April 5, 2016
Autologous stem cell transplantation for patients aged 60 years or older with refractory or relapsed classical Hodgkin's lymphoma: a retrospective analysis from the French Society of Bone Marrow Transplantation and Cell Therapies (SFGM-TC)
A Stamatoullas, P Brice, M S Gueye, et al.
Bone Marrow Transplantation
|
April 29, 2021
Trends in allogeneic haematopoietic cell transplantation for myelofibrosis in Europe between 1995 and 2018: a CMWP of EBMT retrospective analysis
D McLornan, D J Eikema, T Czerw, et al.
Bone Marrow Transplantation
|
June 27, 2017
Clinical impact of NK-cell reconstitution after reduced intensity conditioned unrelated cord blood transplantation in patients with acute myeloid leukemia: analysis of a prospective phase II multicenter trial on behalf of the Société Française de Greffe de Moelle Osseuse et Thérapie Cellulaire and Eurocord
S Nguyen, A Achour, L Souchet, et al.
Bone Marrow Transplantation
|
September 12, 2017
Validation of the revised IPSS at transplant in patients with myelodysplastic syndrome/transformed acute myelogenous leukemia receiving allogeneic stem cell transplantation: a retrospective analysis of the EBMT chronic malignancies working party
C Scheid, L de Wreede, A van Biezen, et al.
Bone Marrow Transplantation
|
December 13, 2016
Long-term survival of patients with CLL after allogeneic transplantation: a report from the European Society for Blood and Marrow Transplantation
M van Gelder, L C de Wreede, M Bornhäuser, et al.
Page
of 30
Search research articles
Search
Showing results (281-290 of 294) with videos related to
Sort By:
Page
of 30
Bone Marrow Transplantation
|
April 26, 2016
Allogeneic stem cell transplantation for patients with mantle cell lymphoma who failed autologous stem cell transplantation: a national survey of the SFGM-TC
B Tessoulin, P Ceballos, P Chevallier, et al.
Journal of Internal Medicine
|
December 8, 2017
Distinct factors determine the kinetics of disease relapse in adults transplanted for acute myeloid leukaemia
C Craddock, J Versluis, M Labopin, et al.
Blood Cancer Journal
|
December 10, 2016
Acute lymphoblastic leukemia relapsing after first-line pediatric-inspired therapy: a retrospective GRAALL study
A Desjonquères, P Chevallier, X Thomas, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
July 13, 2011
Double reduced-intensity allogeneic hematopoietic stem cell transplantation: a retrospective study from the SFGM-TC
J O Bay, A Cabrespine, C Faucher, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 16, 2017
Reduced-intensity versus reduced-toxicity myeloablative fludarabine/busulfan-based conditioning regimens for allografted non-Hodgkin lymphoma adult patients: a retrospective study on behalf of the Société Francophone de Greffe de Moelle et de Thérapie Cellulaire
A Le Bourgeois, M Labopin, D Blaise, et al.
Bone Marrow Transplantation
|
April 5, 2016
Autologous stem cell transplantation for patients aged 60 years or older with refractory or relapsed classical Hodgkin's lymphoma: a retrospective analysis from the French Society of Bone Marrow Transplantation and Cell Therapies (SFGM-TC)
A Stamatoullas, P Brice, M S Gueye, et al.
Bone Marrow Transplantation
|
April 29, 2021
Trends in allogeneic haematopoietic cell transplantation for myelofibrosis in Europe between 1995 and 2018: a CMWP of EBMT retrospective analysis
D McLornan, D J Eikema, T Czerw, et al.
Bone Marrow Transplantation
|
June 27, 2017
Clinical impact of NK-cell reconstitution after reduced intensity conditioned unrelated cord blood transplantation in patients with acute myeloid leukemia: analysis of a prospective phase II multicenter trial on behalf of the Société Française de Greffe de Moelle Osseuse et Thérapie Cellulaire and Eurocord
S Nguyen, A Achour, L Souchet, et al.
Bone Marrow Transplantation
|
September 12, 2017
Validation of the revised IPSS at transplant in patients with myelodysplastic syndrome/transformed acute myelogenous leukemia receiving allogeneic stem cell transplantation: a retrospective analysis of the EBMT chronic malignancies working party
C Scheid, L de Wreede, A van Biezen, et al.
Bone Marrow Transplantation
|
December 13, 2016
Long-term survival of patients with CLL after allogeneic transplantation: a report from the European Society for Blood and Marrow Transplantation
M van Gelder, L C de Wreede, M Bornhäuser, et al.
Page
of 30